U.S. markets closed
  • S&P 500

    4,173.85
    +61.35 (+1.49%)
     
  • Dow 30

    34,382.13
    +360.73 (+1.06%)
     
  • Nasdaq

    13,429.98
    +304.98 (+2.32%)
     
  • Russell 2000

    2,224.63
    +53.68 (+2.47%)
     
  • Crude Oil

    65.51
    +0.14 (+0.21%)
     
  • Gold

    1,844.00
    +5.90 (+0.32%)
     
  • Silver

    27.50
    +0.15 (+0.54%)
     
  • EUR/USD

    1.2151
    +0.0066 (+0.55%)
     
  • 10-Yr Bond

    1.6350
    -0.0330 (-1.98%)
     
  • GBP/USD

    1.4103
    +0.0051 (+0.36%)
     
  • USD/JPY

    109.3470
    -0.0870 (-0.08%)
     
  • BTC-USD

    45,801.32
    -2,587.39 (-5.35%)
     
  • CMC Crypto 200

    1,398.33
    +39.77 (+2.93%)
     
  • FTSE 100

    7,043.61
    +80.28 (+1.15%)
     
  • Nikkei 225

    28,084.47
    +636.47 (+2.32%)
     

NOTICE For Investors In NASDAQ: FBIO Shareholder Notice: Lawsuit against Fortress Biotech, Inc announced by Shareholders Foundation

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Newsfile Corp.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

San Diego, California--(Newsfile Corp. - April 20, 2021) - The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Fortress Biotech, Inc. (NASDAQ: FBIO).

Investors, who purchased shares of Fortress Biotech, Inc. prior to December 11, 2019 and continue to hold any of their NASDAQ: FBIO shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On November 27, 2020, a lawsuit was filed against Fortress Biotech, Inc over alleged violations of securities laws. The plaintiff alleged that the Defendants made false and/or misleading statements and/or failed to disclose that IV Tramadol was not safe for the intended patient population, that as a result, it was foreseeable that the FDA would not approve the NDA for IV Tramadol, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased Fortress Biotech, Inc. (NASDAQ: FBIO) shares should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/80979